Acclivity Small Valuation
| AXVNX Fund | USD 21.45 0.05 0.23% |
At this time, the entity appears to be fairly valued. Acclivity Small Cap shows a prevailing Real Value of $21.08 per share. The current price of the fund is $21.45. We determine the value of Acclivity Small Cap from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Acclivity Small's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Acclivity Small Cap shows a prevailing Real Value of $21.08 per share. The current price of the fund is $21.45. We determine the value of Acclivity Small Cap from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Acclivity Small is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Acclivity Mutual Fund. However, Acclivity Small's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 21.45 | Real 21.08 | Hype 21.4 |
The intrinsic value of Acclivity Small's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Acclivity Small's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Acclivity Small Cap helps investors to forecast how Acclivity mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acclivity Small more accurately as focusing exclusively on Acclivity Small's fundamentals will not take into account other important factors: About Acclivity Small Valuation
Our relative valuation model uses a comparative analysis of Acclivity Small. We calculate exposure to Acclivity Small's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Acclivity Small's related companies.Under normal market conditions, the fund will invest at least 80 percent of its total assets in equity securities of small cap U.S. companies. The Adviser defines a small capitalization value company as any company that simultaneously meets the following two requirements be in the lowest 8 percent of U.S. aggregate market capitalization and exhibit a low market value relative to its book value. The fund will also use futures and options on futures contracts for U.S. equity securities and indices, and exchange-traded-funds to adjust market exposure or manage cash needs.
Other Information on Investing in Acclivity Mutual Fund
Acclivity Small financial ratios help investors to determine whether Acclivity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acclivity with respect to the benefits of owning Acclivity Small security.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |